BCL2 and neoplasm: At the molecular level, the anti-apoptotic proteins Bcl-2/Bcl-xl enable tumor cells to evade programmed cell death by suppressing mitochondrial apoptosis, while the Akt/mTOR signaling pathway promotes tumor growth, metabolic reprogramming, and survival signals [32,33,34].